Myriad Genetics Announces Fourth Quarter and Year-End Fiscal 2008 Financial Results Conference Call

Tuesday, August 19, 2008 at 10:00 a.m. ET

SALT LAKE CITY, UT–(EMWNews – August 12, 2008) – Myriad Genetics, Inc. (NASDAQ: MYGN) has

arranged a conference call with the management team to provide a company

update. Peter D. Meldrum, President and Chief Executive Officer, will host

the call along with Jim Evans, Chief Financial Officer, Gregory C.

Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., and

Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.

DATE: August 19, 2008

TIME: 10:00 am ET

DIAL-IN: 800 736 4594 or +1 212 231 2901

Reservation # 21390875

(Please dial in approximately 10 minutes before the call is scheduled to

begin)

A press release will be issued at 6:30 am ET on August 19, 2008.

Replay of the call will be available from two hours after the call for

seven days by dialing (800) 633-8284 or (402) 977-9140, and entering

reservation number 21390875.

A live audio Webcast will be available at: www.myriad.com